NCT00165659View on ClinicalTrials.gov

A Multi-Center, Randomized, Double-Blind, Parallel Group Study With 3 Groups Receiving Placebo, 5 mg of E2020 and 10 mg of E2020

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

November 30, 2002

Primary Completion Date

May 31, 2005

Conditions
Alzheimer Disease
Interventions
DRUG

DONEPEZIL HYDROCHLORIDE

Trial Locations (65)

470-3411

Chita

466-0065

Nagoya

441-8124

Toyohashi

010-0146

Akita

010-0874

Akita

019-2413

Daisen

277-0004

Kashiwa

910-0046

Fukui-shi

811-1122

Fukuoka

813-0025

Fukuoka

814-0133

Fukuoka

819-0165

Fukuoka

802-0978

Kitakyushu

960-1247

Fukushima

963-1309

Kōriyama

375-0017

Fujioka

378-0014

Numata

730-0011

Hiroshima

734-0037

Hiroshima

739-0651

Ōtake

078-8208

Asahikawa

678-0081

Aio

679-3423

Asago

675-1114

Kako

650-0017

Kobe

653-0013

Kobe

300-0053

Tsuchiura

305-0005

Tsukuba

920-0934

Kanazawa

211-0063

Kawasaki

216-0015

Kawasaki

228-0815

Sagamihara

780-0842

Kochi

600-8212

Kyoto

607-8064

Kyoto

850-0841

Nagasaki

852-8061

Nagasaki

857-0022

Sasebo

634-0813

Kashihara

949-3116

Jōetsu

945-1114

Kashiwazaki

701-0304

Tsukubo

570-0074

Moriguchi

572-0801

Neyagawa

540-0006

Osaka

545-0051

Osaka

558-0056

Osaka

565-0874

Suita

569-1041

Takatsuki

338-0003

Saitama

693-0021

Izumo

424-0911

Shizuoka

329-0431

Kawachi

321-0207

Shimotsuga

101-0024

Chiyoda-ku

193-0944

Hachiōji

189-0002

Higashimurayama

173-0015

Itabashi-ku

187-0031

Kodaira

194-0023

Machida

160-0023

Shinjuku-ku

939-1851

Nanto

644-0002

Gobō

640-8435

Wakayama

747-0065

Hōfu

All Listed Sponsors
lead

Eisai Limited

INDUSTRY

NCT00165659 - A Multi-Center, Randomized, Double-Blind, Parallel Group Study With 3 Groups Receiving Placebo, 5 mg of E2020 and 10 mg of E2020 | Biotech Hunter | Biotech Hunter